HBC ANNUAL REPORT 2024
11.04.2025
CONTEMPLATING UNSECURED BOND ISSUANCE
10.03.2025
HBC ACCELERATES IN HUMAN HEALTH AND PET NUTRITION THROUGH A STRATEGIC PARTNERSHIP WITH SYMRISE TO BUILD OUT BERKÅK, TRIPLING THE MANUFACTURING CAPACITY OF THE GROUP
21.02.2025
PRIMARY INSIDER NOTIFICATION
20.02.2025
FOURTH QUARTER & FULL YEAR 2024 FINANCIAL REPORT
14.02.2025
12.12.2024
Commences the project for a second hydrolysis plant in Norway to triple capacity
05.12.2024
THIRD QUARTER 2024 FINANCIAL REPORT
08.11.2024
CFO RESIGNATION
22.10.2024
HBC IMMUNOLOGY COMPLETES IN VIVO DRUG LEAD STUDIES FOR PROSTATE CANCER TREATMENT
08.10.2024